InvestorsHub Logo
Followers 62
Posts 7553
Boards Moderated 1
Alias Born 01/02/2003

Re: chas1232123 post# 381111

Friday, 06/24/2022 11:46:48 AM

Friday, June 24, 2022 11:46:48 AM

Post# of 426236
Chas....Your note on Vascepa is amazingly well reasoned and constructed The details are convincing to anyone with an open mind...I hope Amarin management and Denner are given your convincing thesis to digest....also, EU agencies responsible for reimbursing patients for Vascepa should read this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News